These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 38960659)

  • 1. [Coagulation and complement crosstalk: molecular mechanisms of complement-mediated diseases].
    Tsujimoto H; Inoue N
    Rinsho Ketsueki; 2024; 65(6):576-583. PubMed ID: 38960659
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Examining coagulation-complement crosstalk: complement activation and thrombosis.
    Foley JH
    Thromb Res; 2016 May; 141 Suppl 2():S50-4. PubMed ID: 27207425
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Therapeutic complement inhibition in complement-mediated hemolytic anemias: Past, present and future.
    Risitano AM; Marotta S
    Semin Immunol; 2016 Jun; 28(3):223-40. PubMed ID: 27346521
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Small-molecule factor D inhibitors selectively block the alternative pathway of complement in paroxysmal nocturnal hemoglobinuria and atypical hemolytic uremic syndrome.
    Yuan X; Gavriilaki E; Thanassi JA; Yang G; Baines AC; Podos SD; Huang Y; Huang M; Brodsky RA
    Haematologica; 2017 Mar; 102(3):466-475. PubMed ID: 27810992
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibition of complement component C5 prevents clotting in an ex vivo model of xenogeneic activation of coagulation.
    Rataj D; Werwitzke S; Haarmeijer B; Winkler M; Ramackers W; Petersen B; Niemann H; Wünsch A; Bähr A; Klymiuk N; Wolf E; Abicht JM; Ayares D; Tiede A
    Xenotransplantation; 2016 Mar; 23(2):117-27. PubMed ID: 26773447
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Complement activation in diseases presenting with thrombotic microangiopathy.
    Meri S
    Eur J Intern Med; 2013 Sep; 24(6):496-502. PubMed ID: 23743117
    [TBL] [Abstract][Full Text] [Related]  

  • 7. It takes two to thrombosis: Hemolysis and complement.
    Delvasto-Nuñez L; Jongerius I; Zeerleder S
    Blood Rev; 2021 Nov; 50():100834. PubMed ID: 33985796
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Complement and Coagulation: Cross Talk Through Time.
    Dzik S
    Transfus Med Rev; 2019 Oct; 33(4):199-206. PubMed ID: 31672340
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Complement in Hemolysis- and Thrombosis- Related Diseases.
    Luo S; Hu D; Wang M; Zipfel PF; Hu Y
    Front Immunol; 2020; 11():1212. PubMed ID: 32754149
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The role of the complement system in kidney glomerular capillary thrombosis.
    Yoshida Y; Nishi H
    Front Immunol; 2022; 13():981375. PubMed ID: 36189215
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Molecular pharmacology in complement-mediated hemolytic disorders.
    Bortolotti M; Barcellini W; Fattizzo B
    Eur J Haematol; 2023 Sep; 111(3):326-336. PubMed ID: 37308291
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Anticomplement C5 therapy with eculizumab for the treatment of paroxysmal nocturnal hemoglobinuria and atypical hemolytic uremic syndrome.
    Wong EK; Kavanagh D
    Transl Res; 2015 Feb; 165(2):306-20. PubMed ID: 25468487
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Properdin Is a Key Player in Lysis of Red Blood Cells and Complement Activation on Endothelial Cells in Hemolytic Anemias Caused by Complement Dysregulation.
    Chen JY; Galwankar NS; Emch HN; Menon SS; Cortes C; Thurman JM; Merrill SA; Brodsky RA; Ferreira VP
    Front Immunol; 2020; 11():1460. PubMed ID: 32793201
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Is COVID-19 associated thrombosis caused by overactivation of the complement cascade? A literature review.
    Fletcher-Sandersjöö A; Bellander BM
    Thromb Res; 2020 Oct; 194():36-41. PubMed ID: 32569879
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Paroxysmal nocturnal hemoglobinuria: a complement-mediated hemolytic anemia.
    DeZern AE; Brodsky RA
    Hematol Oncol Clin North Am; 2015 Jun; 29(3):479-94. PubMed ID: 26043387
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Complement in hemolytic anemia.
    Brodsky RA
    Blood; 2015 Nov; 126(22):2459-65. PubMed ID: 26582375
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The role of complement activation in thrombosis and hemolytic anemias.
    Chapin J; Terry HS; Kleinert D; Laurence J
    Transfus Apher Sci; 2016 Apr; 54(2):191-8. PubMed ID: 27156108
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Oxidative stress in paroxysmal nocturnal hemoglobinuria and other conditions of complement-mediated hemolysis.
    Fibach E; Dana M
    Free Radic Biol Med; 2015 Nov; 88(Pt A):63-9. PubMed ID: 25937178
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Complement Activation and Thrombotic Microangiopathies.
    Palomo M; Blasco M; Molina P; Lozano M; Praga M; Torramade-Moix S; Martinez-Sanchez J; Cid J; Escolar G; Carreras E; Paules C; Crispi F; Quintana LF; Poch E; Rodas L; Goma E; Morelle J; Espinosa M; Morales E; Avila A; Cabello V; Ariceta G; Chocron S; Manrique J; Barros X; Martin N; Huerta A; Fraga-Rodriguez GM; Cao M; Martin M; Romera AM; Moreso F; Manonelles A; Gratacos E; Pereira A; Campistol JM; Diaz-Ricart M
    Clin J Am Soc Nephrol; 2019 Dec; 14(12):1719-1732. PubMed ID: 31694864
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Complement and the prothrombotic state.
    Schmidt CQ; Schrezenmeier H; Kavanagh D
    Blood; 2022 Mar; 139(13):1954-1972. PubMed ID: 34415298
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.